Comparing trifarotene cream vs placebo for moderate acne
Part of Skin clinical trials.
This study tests a cream to treat moderate acne on the face and possibly upper body. It is for Chinese participants aged 9 and older.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 9 years or older.
- You need at least 20 whiteheads/blackheads and 25 red inflamed pimples on your face.
- Your acne must be rated as moderate by the doctor.
- If you are 12 or older, you may also need moderate acne on your chest, shoulders, or upper back (optional for ages 9-11).
- Females who can become pregnant must use birth control throughout the study and for 1 month after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new cream called clascoterone for moderate to severe facial acne. It may help reduce pimples and blackheads with fewer side effects than some other treatments.
This trial tests a cream called KR230109 for mild to moderate facial acne. It aims to see if the cream is safe and works well. You may qualify if you are 18 to 40 and have at least 10 pimples and 20 blackheads or whiteheads on your face, but no deep cysts.
This trial tests a cream called clascoterone (1%) for people ages 12 and up with moderate to severe facial acne. The cream is applied daily to help reduce pimples and clogged pores.
This trial tests three different gel treatments for mild to moderate acne on the face. One gel contains clindamycin and retinoid, another adds dexamethasone, and the third uses a special stem-cell secretion. All are applied to the face for 8 weeks.
This trial compares oral isotretinoin (a strong acne medication) to standard treatments for people with moderate acne and darker skin tones. It aims to find which treatment works best for skin of color.
This trial tests a new medicine, HB0043, to see if it helps adults with moderate to severe facial acne. You cannot use other acne treatments during the study.
Hear when a new Acne Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.